| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.36 | 0.007 |